Φορτώνει......
Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
BACKGROUND: Hydroxyurea (HU) is a non-alkylating antineoplastic agent that is active in the S-phase of the cell cycle and inhibits the enzyme ribonucleoside reductase. HU is currently used to treat leukemia, sickle cell anemia, psoriasis, and chronic myeloproliferative disorders. Although HU is easy...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | World J Clin Cases |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Baishideng Publishing Group Inc
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906572/ https://ncbi.nlm.nih.gov/pubmed/31832413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i23.4091 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|